Mach7 Technologies Ltd. · ASX:M7T
Mach7 Technologies — Wilsons Rapid Insights Conference 2020
24 slides from Mach7 Technologies's conference presentation, May 28, 2020
Slide 1: Wilsons Rapid Insights Conference
Wilsons Rapid Insights Conference 28 May 2020 Mach7 is a leading enterprise imaging software provider for healthcare
Slide 2: Disclaimer 'Forward-Looking' Statements
Disclaimer ‘Forward-Looking’ Statements Summary of information: This presentation contains general and background information about Mach7 Technologies Limited (“M7T”) activities current as at the date of the presentation and should not be considered to be comprehensive or to comprise all the informa
Slide 3: Mach7 Technologies (M7T)
Global • USA Customer • Asia Base • Qatar USA HQ ASEAN Burlington, VT Operations Singapore • SAAS Revenue • Capital Sales Mach7 Technologies Model • Strong Group HQ (M7T) Growth Melbourne (ASX listed “M7T” a leading enterprise ~$130m market cap) imaging software provider for healthcare Software • On
Slide 4: Mach7 Enterprise Imaging Product Strategy
Mach7 Enterprise Imaging Product Strategy Referring Physician Radiologist Vendor Neutral Archive Mach7 sells a Picture Archive and (VNA) is the cornerstone Core Capability is providing Communications System (PACS) of an EI strategy Enterprise Imaging (EI) with its partner Client Outlook Mach
Slide 5: Addressable Global Imaging Market
Addressable Global Imaging Market Mach7 Addressable Market* (US$M) 3,500 • Total Market ~US$3BN – growing 5-6% CAGR 3,000 • Enterprise Imaging Market (EI) $520M* 2018 – forecast growth ~30%* p/a for next two 2,500 years • EI market is the fastest growing market 2,000 • Standalone departmental PACS m
Slide 6: Competition (VNA)
Competition (VNA) Other IBM Watson 14% Health • Mach7 is the only independent VNA 22% company featured on this chart Sectra AB 3% Mach7 • Disruptive technology 3% • Most “big brand names” are selling Agfa Healthcare 4% “VNA” inclusive with other products Carestream 4% • Mach7 is a market leader for
Slide 7: Mach7 Competitive Advantages
Mach7 Competitive Advantages Interoperability across the enterprise (connecting all systems, across all ‘ologies’) Customer controls their Attractive own data – easy Price Point user interface and rules engine Very Little Hardware (Lowers cost and Ease of Install; accelerates install) Quality (& Fas
Slide 8: Global Customer Base
Global Customer Base = SYN Vz NE NW“ = = oy — : yy : = S — = NSS KS Ke = oS SS NNT NNT oN WS WX WX : BIN = REN SSS MACH; TECHNOLOGIES
Slide 9: Our Customers
Our Customers (sample of Mach7’s expanding global customer base) 100% Customer Retention in all Major Markets 9
Slide 10: Advocate Aurora Health
Advocate Aurora Health Mach7 Platform & Migration • Mach7 Platform to be health-network-wide • ~3.5 Petabytes of archived data to migrate • 3.5 Million Annual Procedures • Contract value $5.7M over 5 years • 100% Gross Margin Customer Objectives • Enable scalable and interoperable platform to meet t
Slide 11: Sentara Healthcare
Sentara Healthcare Enterprise Imaging, Migration & PACS Modernisation Projects • Mach7 VNA and 20 million study migration underway • Recent PACS modernization contract won $2.1M over 5 years (+ volume expansion opportunity) • 100% Gross Margin Customer Objectives • Reduce complexities and costs rela
Slide 12: Hospital Authority of Hong Kong
Hospital Authority of Hong Kong Deal value HK$81 Million (~ A$15M) / 5 years Enterprise Imaging and Viewer for entire Hong Kong territory • The Hospital Authority manages 43 public hospitals and institutions, 48 specialist outpatient clinics and 73 general outpatient clinics. Customer Objective: • R
Slide 13: FY20 Highlights
FY 20 Highlights YY, -—“4% _—%“4% Jiper, Ge Ze : “S RX S ARK? NSS = oN Wa — Wt — Ye \ SN . CL: NN aa NNT TS ss. NNT TE 44, SXY NAN > ‘ XS RER KGS YS VE VEN E=SS MACH; TECHNOLOGIES
Slide 14: The Year So Far…
• $23M cash on hand at Q3 Cash • Cash flow positive last 12 months • On target for >$18M FY20 Revenues • >90% growth over FY19 The Year EBITDA • On Target for First FY Positive EBITDA So Far… CARR • $9.2M per annum, contracted support • Advocate Aurora (USA) $5.7M (5 yr contract) • Hospital Authorit
Slide 15: Sales Pipeline
Sales Pipeline Sales • 24 new deals added Pipeline • >$20M Growth H2 20 • 9 active RFPs Active RFPs • ~$30M 15
Slide 16: Annual Recurring Revenue (ARR, CARR)
Annual Recurring Revenue (ARR, CARR) CARR and ARR Tracking 10,000,000 9,000,000 8,000,000 7,000,000 6,000,000 5,000,000 4,000,000 3,000,000 2,000,000 1,000,000 0 2017 2018 2019 2020 (YTD APRIL) CARR Recognised AR + Sub Contracted Recurring Revenue (“CARR”) is derived from software support & subscrip
Slide 17: Looking Ahead
Looking Ahead —% —w4 “4, ——Le pin Vip : \Y KG N RK<S \ Ke =— Pe RO SONNET Oe . ee . ~“ - SNS Ox SS SS — KGS | aN (Za MACH; TECHNOLOGIES
Slide 18: Beyond FY20
Beyond FY20 Growth Acceleration • $23 million cash, debt free and positioned for future growth • Target potential acquisition of complementary technologies to accelerate growth • Strengthen sales team and invest more in marketing Profitability • Build on EBITDA FY20 result • Continue free cash flow
Slide 19: Investment Thesis
Investment Thesis Med-Tech-Thematic • No obvious ASX alternative for pure exposure to Enterprise Imaging • Disruptive Technology Strong Financials Pending Catalysts High Proportion of • • Recurring Revenue High (>80%) gross $$ $ • • • FY20 profitability FY20 revenues $18M Customer wins margins • M&A
Slide 20: Thank You!
Thank You! Mike Lampron Managing Director Mike.Lampron@mach7t.com +1 845 5547277 Jenni Pilcher CFO, Company Secretary Jenni.Pilcher@mach7t.com +61 424 750737 20
Slide 21: Appendices
Appendices PRODUCT INFORMATION
Slide 22: Mach7 Enterprise Imaging Platform
Mach7 Enterprise Imaging Platform With an industry recognized best-of-breed enterprise platform, Solutions Features Mach7 Management Studio solutions deliver control and ownership over your clinical images and content. Enterprise Imaging Platform • • Vendor Neutral Archive (VNA) Communication Workfl
Slide 23: Mach7 Clinical Studio
Mach7 Clinical Studio Mach7 Clinical Solutions Mach7 Clinical Studio delivers workflows for clinical end users and patients that simplify the access, capture, import, and sharing of the patient record across departments and traditional boundaries. Solutions Features Clinical Viewer • Zero install br
Slide 24: Mach7 Diagnostic Studio
Mach7 Diagnostic Studio Mach7 Diagnostic Solutions (PACS) Mach7 Diagnostics Studio advances PACS with intelligent Solutions Features vendor neutral workflow and data management Enterprise PACS Universal Worklist capabilities while delivering diagnostic viewing • • QC Workflow technologies through pr
Mach7 Technologies — Wilsons Rapid Insights Conference 2020 on 6ix